James Rathbone

James Rathbone

Auto-generated profile, based on publicly available information

James Rathbone

Nottinghamshire Healthcare NHS Foundation Trust, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Journal of Health Psychology
Verified
Journal Article
Open access
CBClement Boutry
Clement Boutry
JRJames Rathbone
James Rathbone
FGFelicity Gibbons
Felicity Gibbons
DBDan Brooks
Dan Brooks
NMNima Moghaddam
Nima Moghaddam
SMSam Malins
Sam Malins
This study explored participant-reported facilitators and barriers to learning and implementation from a 2-day training in psychological assessment and intervention skills for cancer staff, involving deliberate practice and supervision. Twenty-six semi-structured interviews were analysed using thematic analysis leading to four meta-themes: perceived practicality of training, impact of training: practice and its effects, implementation transfer processes and supervision engagement. Analysis identified a learning process to implementation: observation and practice of techniques during training facilitated participant learning; personal use and relevance of training content encouraged reflection, which enabled selection of appropriate tools for clinical practice; gains in commitment and confidence to use techniques supported participants to adapt clinical consultations, and supervision further facilitated implementation. Changing practice increased confidence, sense of achievement and engagement with participants’ own wellbeing. Interactive training, deliberate practice and continuous learning were facilitators to implementation whilst time constraint and low confidence in using techniques in remote consultations were barriers.

13 September 2023 in Medical Education
Verified
Journal Article
Open access
SMSam Malins
Sam Malins
CBClement Boutry
Clement Boutry
NGNima Golijani-Moghaddam
Nima Golijani-Moghaddam
JRJames Rathbone
James Rathbone
FGFelicity Gibbons
Felicity Gibbons
JLJoanna Levene
Joanna Levene

12 June 2026 in JMIR Preprints
Verified
Preprint
Open access
JRJames Rathbone
James Rathbone
CMCatherine Macauley
Catherine Macauley
MCMelissa Covington
Melissa Covington
FMFallon Mauger
Fallon Mauger
AHAdam Hill
Adam Hill
NGNima Golijani-Moghaddam
Nima Golijani-Moghaddam
BACKGROUND Anxiety and depression are common among people living with and beyond cancer and frequently recur following the completion of psychological therapy. Digital interventions may offer a scalable and cost-effective means of supporting relapse prevention, but evidence in cancer populations remains limited. OBJECTIVE This study evaluated the feasibility, acceptability, and potential effectiveness of a personalized relapse prevention planning intervention supported by personalized smart-messaging following discharge from psychological therapy for cancer-related anxiety and depression. METHODS A naturalistic, non-randomized quasi-experimental cohort study was conducted within a National Health Service cancer psychology service in England. Patients completing psychological therapy could opt to receive a relapse prevention planning session followed by 26 weeks of personalized smart-messaging (relapse prevention planning [RPP]) or receive treatment as usual (TAU). Outcomes were assessed at discharge and 6- and 12-month follow-up using the Patient Health Questionnaire-9 (PHQ-9; primary outcome), Generalized Anxiety Disorder-7 (GAD-7), and Work and Social Adjustment Scale (WSAS). Linear mixed-effects models examined differences between groups over time while controlling for pre-treatment severity. Feasibility and acceptability were assessed through recruitment, retention, engagement, and withdrawal rates. RESULTS Of 84 eligible patients approached, 57 (68%) consented to participate and 29 (56%) completed the final follow-up assessment. Engagement with smart-messaging was high: 92% of participants responded to at least one weekly prompt and there were no withdrawals from the messaging intervention. For depression, the RPP group demonstrated significantly lower PHQ-9 scores across follow-up than TAU (adjusted mean 6.08, SE 0.95 vs 10.46, SE 0.97; F1,44.9=9.90, P=.003). Significant between-group differences were observed at 6 months (mean difference 5.92, 95% CI 2.40-9.44; P=.001; d=1.08) and 12 months (mean difference 5.41, 95% CI 1.76-9.07; P=.005; d=1.06). The group × time interaction was not statistically significant (F2,36.3=2.73, P=.079). For anxiety, the RPP group reported lower GAD-7 scores than TAU (mean difference 3.80, 95% CI 1.35-6.25; F1,49.8=9.73, P=.003), although the interaction effect was not significant (F2,37.4=0.04, P=.965). Functional impairment showed a similar pattern, with a significant advantage for RPP at 6 months (mean difference 9.09; P=.029; d=1.16), but the overall group effect did not reach statistical significance (F1,20.0=4.08, P=.057). CONCLUSIONS Personalized relapse prevention planning supported by smart-messaging was feasible, highly acceptable, and associated with sustained improvements in depression and anxiety following psychological therapy for cancer patients. Although findings are promising, the non-randomized design limits causal inference. A fully powered randomized controlled trial is warranted.

18 April 2026 in PsyArXiv
Verified
Preprint
Open access
PHPaulina Hunt
Paulina Hunt
MCMelissa Covington
Melissa Covington
NGNima Golijani-Moghaddam
Nima Golijani-Moghaddam
KMKate Maguire
Kate Maguire
SMSam Malins
Sam Malins
FGFelicity Gibbons
Felicity Gibbons
Background: Prehabilitation aims to optimise patients’ physical and psychological readiness for surgery. Evidence for exercise-based prehabilitation is well-established, but evidence on the effectiveness of embedded psychological therapy in cancer prehabilitation remains limited.Aims: To evaluate whether brief, rapid‑response psychological therapy embedded within a multimodal cancer prehabilitation pathway improves mental health and functional outcomes, and to compare outcomes for patients who received specialist psychological support versus those who did not .Methods: This study applied a non‑randomised, prospective cohort comparison design using routine data from two UK NHS multimodal prehabilitation services. Participants were cancer patients using the prehabilitation pathway who reported clinically significant symptoms of anxiety and/or depression. Analysis 1 examined longitudinal change in depression and anxiety in patients referred for specialist psy chological support (n = 135) across baseline, mid‑therapy, and post‑intervention. Analysis 2 compared standardised mean differences in affective and functional outcomes for patients who accessed psychological support (n = 60) with eligible patients who declined (n = 418).Results: In Analysis 1, mean depression scores decreased by 54.1% and anxiety by 39.2%, with recovery rates comparable to and achieved in fewer sessions than national benchmarks for NHS Talking Therapies. In Analysis 2, both groups improved across all measures; standardised mean differences were numerically larger in the supported group for depression, anxiety, and sit‑to‑stand assessments. Conclusions: Initial indications suggest that embedding brief psychological input within prehabilitation is associated with clinically meaningful improvements in both mental health and functional outcomes linked to recovery. F urther research with randomised controlled designs is warranted to confirm causality and inform implementation.